EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Signal detection and characterisation of a novel drug–drug interaction between methadone and a synthetic cannabinoid receptor agonist

Kirsten L Rock iD, Louise M Hesketh iD, Hongwei Cheng iD, Shuoqi Chen iD, Simon Hudson iD, Graeme Henderson iD, Jules C Hancox iD, Michael J Shattock iD, Michael J Curtis iD, Caroline S Copeland iD

British Journal of Pharmacology · 2026-12 · 183 (23) · 6787-6800

DOI: 10.1111/bph.70635 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 14.08.2026. Verfasst von Kirsten L Rock und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science, King's College London, London, UK. Hauptthemen laut MEDLINE: Methadone, Cannabinoid Receptor Agonists, Cannabinoids. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Society for the Study of Addiction (SSA), British Heart Foundation, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Little is known about how synthetic cannabinoid receptor agonist (SCRA) co‐use with other psychoactive substances may exacerbate risk of death. This study aimed to characterise the polypharmacy of deaths where SCRAs were detected at post‐mortem, investigate the cardiotoxicity of SCRAs and probe their inhibition of human ether‐a‐go‐go‐related gene (hERG) channel function. Experimental Approach Deaths with detections of SCRA(s) were analysed from the National Programme on Substance Use Mortality. Isolated hearts from guinea pigs were perfused with modified Krebs solution. Methadone and the SCRA 5F‐ADB (5F‐MDMB‐PINACA) were applied singly and in combination, with electrocardiogram recording. Software tools and patch‐clamp electrophysiology were employed to investigate 5F‐ADB–hERG channel interaction. Key Results In deaths with SCRA detections, pharmacoepidemiological analyses showed that methadone was the most commonly co‐detected medication with long QT liability. Sub‐analysis of SCRA–methadone deaths revealed a significantly lower median blood concentration of methadone proved fatal, compared to deaths solely attributed to methadone. In perfused guinea pig hearts, sole application of methadone, but not 5F‐ADB, prolonged the QTc interval, compared to baseline. Co‐application significantly increased the QTc interval. The in silico and in vitro analyses showed 5F‐ADB to be a low affinity hERG channel inhibitor. Conclusions and Implications The reduction in the toxicity threshold of methadone and the facilitation of its QT prolongation by the SCRA 5F‐ADB suggests the former may result from pro‐arrhythmia. Use of QT‐prolonging medications by people who use SCRAs may result in a drug–drug interaction that increases the risk of pro‐arrhythmic death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethadoneCannabinoid Receptor AgonistsCannabinoidsAnimalsGuinea PigsDrug InteractionsMaleHumansEther-A-Go-Go Potassium ChannelsElectrocardiographyHeartERG1 Potassium Channel

Stichwörter der Autor:innen

QT intervaldrug interactionharm reductionmethadonespicesynthetic cannabinoid

Substanzen

MethadoneCannabinoid Receptor AgonistsCannabinoidsEther-A-Go-Go Potassium Channels5F-ADB cannabinoidERG1 Potassium Channel

Autor:innen und Institutionen

  • Centre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science, King's College London, London, UK.
  • School of Cardiovascular and Metabolic Medicine and Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.
  • LGC Limited - Sport and Specialised Analytical Services, Fordham, UK.

ORCID-Profile: Kirsten L Rock, Louise M Hesketh, Hongwei Cheng, Shuoqi Chen, Simon Hudson, Graeme Henderson, Jules C Hancox, Michael J Shattock, Michael J Curtis, Caroline S Copeland

Förderung

  • Society for the Study of Addiction (SSA)
  • British Heart Foundation
  • Medical Research Council

Zitieren

APA

Rock, K. L., Hesketh, L. M., Cheng, H., Chen, S., Hudson, S., Henderson, G., Hancox, J. C., Shattock, M. J., Curtis, M. J., & Copeland, C. S. (2026). Signal detection and characterisation of a novel drug–drug interaction between methadone and a synthetic cannabinoid receptor agonist. British Journal of Pharmacology, 183(23), 6787-6800. https://doi.org/10.1111/bph.70635

Vancouver

Rock KL, Hesketh LM, Cheng H, Chen S, Hudson S, Henderson G, et al. Signal detection and characterisation of a novel drug–drug interaction between methadone and a synthetic cannabinoid receptor agonist. British Journal of Pharmacology. 2026;183(23):6787-6800. doi:10.1111/bph.70635

BibTeX
@article{Rock2026,
  author = {Rock, Kirsten L and Hesketh, Louise M and Cheng, Hongwei and Chen, Shuoqi and Hudson, Simon and Henderson, Graeme and Hancox, Jules C and Shattock, Michael J and Curtis, Michael J and Copeland, Caroline S},
  title = {Signal detection and characterisation of a novel drug–drug interaction between methadone and a synthetic cannabinoid receptor agonist},
  journal = {British Journal of Pharmacology},
  year = {2026},
  volume = {183},
  number = {23},
  pages = {6787--6800},
  doi = {10.1111/bph.70635}
}
Kostenlos starten →